When Oliver Sacks arrived in New York City, in September, 1965, he wore a butter-colored suit that reminded him of the sun. He had just spent a romantic week in Europe travelling with a man named Jenö ...

After the U.S. Supreme Court this week said it will hear a case focused on the same federal law, a judge on Thursday put on hold a long-running lawsuit about whether Florida medical-marijuana patients ...

A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy lived dramatically longer than those who didn’t. Researchers from the ...

A recent study from cybersecurity company Proofpoint and Ponemon shows that 93 percent of healthcare organizations experienced at least one cyberattack in the past year. This was an average of 43 ...

Introduction Tobacco use accounts for approximately 1.35 million deaths annually in India, disproportionately affecting low-income individuals, men, rural residents, those without formal education and ...

Researchers have developed an AI system called Dr. CaBot that spells out its reasoning as it works through challenging medical cases and reaches a diagnosis. For the first time, the New England ...

A Brandon single mom suffered a stroke two days after emergency room visit for severe headache. Chiaka Stewart may receive only a fraction of the $70.8 million awarded to her by a jury following a ...

This is not the place to analyze the details of former FBI Director James Comey’s indictment because we don’t know what those details are. Prosecutors will soon have to come up with a bill of ...

WASHINGTON, Sept. 18, 2025 /PRNewswire/ -- The Most Favored Nation model intended to reduce drug prices in the U.S. could negatively impact patient access, according to a new Apteka policy brief ...

Frequently, patients with advanced cancer simply want to be made as comfortable as possible as they wind down their final days. Doctors aren't listening to their desires, a new study indicates. Many ...

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today shared another compelling patient case study in which ...